{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T00:49:23Z","timestamp":1794962963655,"version":"4.9.1"},"reference-count":98,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Urology"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.eururo.2025.12.015","type":"journal-article","created":{"date-parts":[[2025,12,24]],"date-time":"2025-12-24T20:22:19Z","timestamp":1766607739000},"page":"32-43","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Testosterone Therapy in Adult Males with Hypogonadism"],"prefix":"10.1016","volume":"90","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0040-784X","authenticated-orcid":false,"given":"Luca","family":"Boeri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Masterson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leen","family":"Antonio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Corona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohit","family":"Khera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Salonia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John P.","family":"Mulhall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.eururo.2025.12.015_b0005","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.eururo.2025.02.026","article-title":"European Association of Urology guidelines on male sexual and reproductive health: 2025 update on male infertility","volume":"87","author":"Minhas","year":"2025","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2025.12.015_b0010","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.eururo.2025.04.010","article-title":"European Association of Urology guidelines on male sexual and reproductive health: 2025 update on male hypogonadism, erectile dysfunction, premature ejaculation, and Peyronie\u2019s disease","volume":"88","author":"Salonia","year":"2025","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2025.12.015_b0015","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1007\/BF03345775","article-title":"Epidemiology, diagnosis, and treatment of male hypogonadotropic hypogonadism","volume":"32","author":"Lenzi","year":"2009","journal-title":"J Endocrinol Invest"},{"key":"10.1016\/j.eururo.2025.12.015_b0020","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.7326\/M23-0342","article-title":"Factors associated with circulating sex hormones in men: individual participant data meta-analyses","volume":"176","author":"Marriott","year":"2023","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.eururo.2025.12.015_b0025","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1080\/17446651.2023.2296022","article-title":"Advances in the treatment of functional male hypogonadism","volume":"19","author":"Corona","year":"2024","journal-title":"Expert Rev Endocrinol Metab"},{"key":"10.1016\/j.eururo.2025.12.015_b0030","doi-asserted-by":"crossref","first-page":"126","DOI":"10.3390\/jcm8010126","article-title":"Evidence for a common genetic origin of classic and milder adult-onset forms of isolated hypogonadotropic hypogonadism","volume":"8","author":"Cangiano","year":"2019","journal-title":"J Clin Med"},{"key":"10.1016\/j.eururo.2025.12.015_b0035","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1016\/j.jsxm.2016.10.009","article-title":"Diagnosis and treatment of testosterone deficiency: recommendations from the Fourth International Consultation for Sexual Medicine (ICSM 2015)","volume":"13","author":"Khera","year":"2016","journal-title":"J Sex Med"},{"key":"10.1016\/j.eururo.2025.12.015_b0040","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1093\/sxmrev\/qeaf025","article-title":"The hormonal regulation of men\u2019s sexual desire, arousal, and penile erection: recommendations from the fifth international consultation on sexual medicine (ICSM 2024)","volume":"13","author":"Rastrelli","year":"2025","journal-title":"Sex Med Rev"},{"key":"10.1016\/j.eururo.2025.12.015_b0045","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1111\/andr.12770","article-title":"European Academy of Andrology (EAA) guidelines on investigation, treatment and monitoring of functional hypogonadism in males: Endorsing organization: European Society of Endocrinology","volume":"8","author":"Corona","year":"2020","journal-title":"Andrology"},{"key":"10.1016\/j.eururo.2025.12.015_b0050","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.juro.2018.03.115","article-title":"Evaluation and management of testosterone deficiency: AUA guideline","volume":"200","author":"Mulhall","year":"2018","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2025.12.015_b0055","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1210\/jc.2018-00229","article-title":"Testosterone therapy in men with hypogonadism: an Endocrine Society clinical practice guideline","volume":"103","author":"Bhasin","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.eururo.2025.12.015_b0060","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1056\/NEJMoa0911101","article-title":"Identification of late-onset hypogonadism in middle-aged and elderly men","volume":"363","author":"Wu","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.eururo.2025.12.015_b0065","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.1007\/s40618-022-01859-7","article-title":"Adult- and late-onset male hypogonadism: the clinical practice guidelines of the Italian Society of Andrology and Sexual Medicine (SIAMS) and the Italian Society of Endocrinology (SIE)","volume":"45","author":"Isidori","year":"2022","journal-title":"J Endocrinol Invest"},{"key":"10.1016\/j.eururo.2025.12.015_b0070","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1210\/jc.2009-1796","article-title":"Characteristics of secondary, primary, and compensated hypogonadism in aging men: evidence from the European Male Ageing Study","volume":"95","author":"Tajar","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.eururo.2025.12.015_b0075","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1007\/BF03349232","article-title":"Which patients with sexual dysfunction are suitable for testosterone replacement therapy?","volume":"30","author":"Morelli","year":"2007","journal-title":"J Endocrinol Invest"},{"key":"10.1016\/j.eururo.2025.12.015_b0080","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1056\/NEJMra2404637","article-title":"Testosterone treatment in middle-aged and older men with hypogonadism","volume":"393","author":"Bhasin","year":"2025","journal-title":"N Engl J Med"},{"key":"10.1016\/j.eururo.2025.12.015_b0085","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1007\/s40618-015-0425-1","article-title":"How to define hypogonadism? Results from a population of men consulting for sexual dysfunction","volume":"39","author":"Rastrelli","year":"2016","journal-title":"J Endocrinol Invest"},{"key":"10.1016\/j.eururo.2025.12.015_b0090","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1007\/s40618-021-01702-5","article-title":"Testosterone supplementation and bone parameters: a systematic review and meta-analysis study","volume":"45","author":"Corona","year":"2022","journal-title":"J Endocrinol Invest"},{"key":"10.1016\/j.eururo.2025.12.015_b0095","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1007\/s40618-023-02056-w","article-title":"Bone quality in endocrine diseases: determinants and clinical relevance","volume":"46","author":"Cianferotti","year":"2023","journal-title":"J Endocrinol Invest"},{"key":"10.1016\/j.eururo.2025.12.015_b0100","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1007\/s11154-022-09738-5","article-title":"Bone health in ageing men","volume":"23","author":"David","year":"2022","journal-title":"Rev Endocr Metab Disord"},{"key":"10.1016\/j.eururo.2025.12.015_b0105","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1210\/jc.2016-2935","article-title":"Harmonized reference ranges for circulating testosterone levels in men of four cohort studies in the United States and Europe","volume":"102","author":"Travison","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.eururo.2025.12.015_b0110","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s12020-018-1741-y","article-title":"Oral glucose load and mixed meal feeding lowers testosterone levels in healthy eugonadal men","volume":"63","author":"Gagliano-Juc\u00e1","year":"2019","journal-title":"Endocrine"},{"key":"10.1016\/j.eururo.2025.12.015_b0115","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1111\/j.1365-2265.2007.02976.x","article-title":"Intraindividual variation in levels of serum testosterone and other reproductive and adrenal hormones in men","volume":"67","author":"Brambilla","year":"2007","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.eururo.2025.12.015_b0120","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1080\/14656566.2024.2306832","article-title":"Testosterone replacement therapy: clinical considerations","volume":"25","author":"Luther","year":"2024","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.eururo.2025.12.015_b0125","doi-asserted-by":"crossref","first-page":"4542","DOI":"10.1210\/jc.2010-1314","article-title":"Toward excellence in testosterone testing: a consensus statement","volume":"95","author":"Rosner","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.eururo.2025.12.015_b0130","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1530\/EJE-11-1051","article-title":"Comparison of serum testosterone and estradiol measurements in 3174 European men using platform immunoassay and mass spectrometry; relevance for the diagnostics in aging men","volume":"166","author":"Huhtaniemi","year":"2012","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.eururo.2025.12.015_b0135","doi-asserted-by":"crossref","first-page":"3666","DOI":"10.1210\/jcem.84.10.6079","article-title":"A critical evaluation of simple methods for the estimation of free testosterone in serum","volume":"84","author":"Vermeulen","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.eururo.2025.12.015_b0140","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1530\/EC-20-0183","article-title":"SHBG levels in primary infertile men: a critical interpretation in clinical practice","volume":"9","author":"Boeri","year":"2020","journal-title":"Endocr Connect"},{"key":"10.1016\/j.eururo.2025.12.015_b0145","doi-asserted-by":"crossref","first-page":"e641","DOI":"10.1210\/clinem\/dgae280","article-title":"SHBG gene polymorphisms and their influence on serum SHBG, total and free testosterone concentrations in men","volume":"110","author":"Walravens","year":"2025","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.eururo.2025.12.015_b0150","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/s11154-015-9322-3","article-title":"The role of prolactin in andrology: what is new?","volume":"16","author":"Rastrelli","year":"2015","journal-title":"Rev Endocr Metab Disord"},{"key":"10.1016\/j.eururo.2025.12.015_b0155","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1111\/cen.13015","article-title":"The prevalence of structural pituitary abnormalities by MRI scanning in men presenting with isolated hypogonadotrophic hypogonadism","volume":"84","author":"Dalvi","year":"2016","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.eururo.2025.12.015_b0160","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1007\/s40618-021-01586-5","article-title":"Biochemical predictors of structural hypothalamus-pituitary abnormalities detected by magnetic resonance imaging in men with secondary hypogonadism","volume":"44","author":"Cipriani","year":"2021","journal-title":"J Endocrinol Invest"},{"key":"10.1016\/j.eururo.2025.12.015_b0165","doi-asserted-by":"crossref","first-page":"926","DOI":"10.4158\/EP-2018-0609","article-title":"Pituitary imaging by MRI and its correlation with biochemical parameters in the evaluation of men with hypogonadotropic hypogonadism","volume":"25","author":"Das","year":"2019","journal-title":"Endocr Pract"},{"key":"10.1016\/j.eururo.2025.12.015_b0170","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1111\/andr.13525","article-title":"Practice and development of male contraception: European Academy of Andrology and American Society of Andrology guidelines","volume":"12","author":"Wang","year":"2024","journal-title":"Andrology"},{"key":"10.1016\/j.eururo.2025.12.015_b0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.coph.2022.102323","article-title":"Pharmacotherapy of male hypogonadism","volume":"68","author":"Rastrelli","year":"2023","journal-title":"Curr Opin Pharmacol"},{"key":"10.1016\/j.eururo.2025.12.015_b0180","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1111\/andr.262","article-title":"Factors affecting spermatogenesis upon gonadotropin-replacement therapy: a meta-analytic study","volume":"2","author":"Rastrelli","year":"2014","journal-title":"Andrology"},{"key":"10.1016\/j.eururo.2025.12.015_b0185","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1093\/sxmrev\/qeaf036","article-title":"Male hypogonadism: recommendations from the Fifth International Consultation on Sexual Medicine (ICSM 2024)","volume":"13","author":"Khera","year":"2025","journal-title":"Sex Med Rev"},{"key":"10.1016\/j.eururo.2025.12.015_b0190","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.eururo.2020.09.046","article-title":"EAU-EANM-ESTRO-ESUR-SIOG guidelines on prostate cancer. Part II\u20142020 update: treatment of relapsing and metastatic prostate cancer","volume":"79","author":"Cornford","year":"2021","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2025.12.015_b0195","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1007\/BF03347072","article-title":"Androgen regulation of prostate cancer: where are we now?","volume":"34","author":"Corona","year":"2011","journal-title":"J Endocrinol Invest"},{"key":"10.1016\/j.eururo.2025.12.015_b0200","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1056\/NEJMoa2215025","article-title":"Cardiovascular safety of testosterone-replacement therapy","volume":"389","author":"Lincoff","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.eururo.2025.12.015_b0205","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1056\/NEJMoa1506119","article-title":"Effects of testosterone treatment in older men","volume":"374","author":"Snyder","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.eururo.2025.12.015_b0210","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/S2213-8587(20)30367-3","article-title":"Testosterone treatment to prevent or revert type 2 diabetes in men enrolled in a lifestyle programme (T4DM): a randomised, double-blind, placebo-controlled, 2-year, phase 3b trial","volume":"9","author":"Wittert","year":"2021","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.eururo.2025.12.015_b0215","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1080\/0284186X.2023.2278189","article-title":"Testosterone replacement therapy is not associated with increased prostate cancer incidence, prostate cancer-specific, or cardiovascular disease-specific mortality in Finnish men","volume":"62","author":"Siltari","year":"2023","journal-title":"Acta Oncol"},{"key":"10.1016\/j.eururo.2025.12.015_b0220","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.1009900","article-title":"The effect of different administrations of testosterone therapy on adverse prostate events: a Bayesian network meta-analysis","volume":"13","author":"Zeng","year":"2022","journal-title":"Front Endocrinol"},{"key":"10.1016\/j.eururo.2025.12.015_b0225","article-title":"Incidence of prostate cancer in men with testosterone deficiency and a family history of prostate cancer receiving testosterone therapy: a comparative study","volume":"4","author":"Pozzi","year":"2025","journal-title":"BMJ Oncol"},{"key":"10.1016\/j.eururo.2025.12.015_b0230","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.juro.2013.02.002","article-title":"Testosterone replacement therapy in patients with prostate cancer after radical prostatectomy","volume":"190","author":"Pastuszak","year":"2013","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2025.12.015_b0235","first-page":"27","article-title":"Testosterone therapy in men after radical prostatectomy for low-intermediate organ-confined prostate cancer","volume":"213","author":"Flores","year":"2025","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2025.12.015_b0240","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1038\/s41391-020-0241-3","article-title":"Testosterone therapy does not increase the risks of prostate cancer recurrence or death after definitive treatment for localized disease","volume":"23","author":"Sarkar","year":"2020","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"10.1016\/j.eururo.2025.12.015_b0245","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1210\/clinem\/dgae334","article-title":"Prostate risk and monitoring during testosterone replacement therapy","volume":"109","author":"Bhasin","year":"2024","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.eururo.2025.12.015_b0250","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1080\/14740338.2024.2337741","article-title":"Cardiovascular safety of testosterone replacement therapy in men: an updated systematic review and meta-analysis","volume":"23","author":"Corona","year":"2024","journal-title":"Expert Opin Drug Saf"},{"key":"10.1016\/j.eururo.2025.12.015_b0255","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1136\/jim-2017-000411","article-title":"Testosterone treatment and cardiovascular and venous thromboembolism risk: what is \u201cnew\u201d?","volume":"65","author":"Corona","year":"2017","journal-title":"J Investig Med"},{"key":"10.1016\/j.eururo.2025.12.015_b0260","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/s41572-019-0087-y","article-title":"Paediatric and adult-onset male hypogonadism","volume":"5","author":"Salonia","year":"2019","journal-title":"Nat Rev Dis Primer"},{"key":"10.1016\/j.eururo.2025.12.015_b0265","doi-asserted-by":"crossref","first-page":"65","DOI":"10.5534\/wjmh.2017.35.2.65","article-title":"Testosterone replacement therapy: long-term safety and efficacy","volume":"35","author":"Corona","year":"2017","journal-title":"World J Mens Health"},{"key":"10.1016\/j.eururo.2025.12.015_b0270","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1111\/andr.70062","article-title":"Cardiovascular safety of testosterone therapy\u2014insights from the TRAVERSE trial and beyond: a position statement of the European Expert Panel for Testosterone Research","volume":"14","author":"Zitzmann","year":"2026","journal-title":"Andrology"},{"key":"10.1016\/j.eururo.2025.12.015_b0275","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1001\/jama.2016.21041","article-title":"Association between direct-to-consumer advertising and testosterone testing and initiation in the United States, 2009\u20132013","volume":"317","author":"Layton","year":"2017","journal-title":"JAMA"},{"key":"10.1016\/j.eururo.2025.12.015_b0280","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.thromres.2020.12.029","article-title":"Testosterone replacement therapy and the risk of venous thromboembolism: a systematic review and meta-analysis of randomized controlled trials","volume":"199","author":"Ayele","year":"2021","journal-title":"Thromb Res"},{"key":"10.1016\/j.eururo.2025.12.015_b0285","article-title":"Association of genetically predicted testosterone with thromboembolism, heart failure, and myocardial infarction: Mendelian randomisation study in UK Biobank","volume":"364","author":"Luo","year":"2019","journal-title":"BMJ"},{"key":"10.1016\/j.eururo.2025.12.015_b0290","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.sxmr.2020.04.004","article-title":"Obstructive sleep apnea and testosterone therapy","volume":"9","author":"Payne","year":"2021","journal-title":"Sex Med Rev"},{"key":"10.1016\/j.eururo.2025.12.015_b0295","doi-asserted-by":"crossref","first-page":"3096","DOI":"10.1210\/jc.2016-1645","article-title":"Testosterone treatment and sexual function in older men with low testosterone levels","volume":"101","author":"Cunningham","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.eururo.2025.12.015_b0300","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1001\/jamainternmed.2016.9539","article-title":"Effect of testosterone treatment on volumetric bone density and strength in older men with low testosterone: a controlled clinical trial","volume":"177","author":"Snyder","year":"2017","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.eururo.2025.12.015_b0305","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1001\/jamainternmed.2016.9540","article-title":"Association of testosterone levels with anemia in older men: a controlled clinical trial","volume":"177","author":"Roy","year":"2017","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.eururo.2025.12.015_b0310","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1210\/jc.2017-02243","article-title":"The effect of testosterone on cardiovascular biomarkers in the testosterone trials","volume":"103","author":"Mohler","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.eururo.2025.12.015_b0315","doi-asserted-by":"crossref","first-page":"e3143","DOI":"10.1210\/clinem\/dgab149","article-title":"Effect of testosterone treatment on bone microarchitecture and bone mineral density in men: a 2-year RCT","volume":"106","author":"Ng Tang Fui","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.eururo.2025.12.015_b0320","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1056\/NEJMoa2308836","article-title":"Testosterone treatment and fractures in men with hypogonadism","volume":"390","author":"Snyder","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1016\/j.eururo.2025.12.015_b0325","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1210\/clinem\/dgad484","article-title":"Effect of testosterone replacement therapy on sexual function and hypogonadal symptoms in men with hypogonadism","volume":"109","author":"Pencina","year":"2024","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.eururo.2025.12.015_b0330","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1001\/jamainternmed.2023.7862","article-title":"Effect of testosterone on progression from prediabetes to diabetes in men with hypogonadism: a substudy of the TRAVERSE randomized clinical trial","volume":"184","author":"Bhasin","year":"2024","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.eururo.2025.12.015_b0335","doi-asserted-by":"crossref","DOI":"10.1016\/j.beem.2022.101615","article-title":"Androgens and male sexual function","volume":"36","author":"Corona","year":"2022","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"10.1016\/j.eururo.2025.12.015_b0340","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1111\/andr.13367","article-title":"Testosterone therapy in diabetes and pre-diabetes","volume":"11","author":"Corona","year":"2023","journal-title":"Andrology"},{"key":"10.1016\/j.eururo.2025.12.015_b0345","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1007\/s40618-023-02136-x","article-title":"Metabolic syndrome and erectile dysfunction: a systematic review and meta-analysis study","volume":"46","author":"Corona","year":"2023","journal-title":"J Endocrinol Invest"},{"key":"10.1016\/j.eururo.2025.12.015_b0350","doi-asserted-by":"crossref","first-page":"R99","DOI":"10.1530\/EJE-15-0262","article-title":"Therapy of endocrine disease: testosterone supplementation and body composition: results from a meta-analysis study","volume":"174","author":"Corona","year":"2016","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.eururo.2025.12.015_b0355","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1530\/EJE-21-0473","article-title":"Effectiveness of testosterone replacement in men with obesity: a systematic review and meta-analysis","volume":"186","author":"Mangolim","year":"2021","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.eururo.2025.12.015_b0360","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1080\/17512433.2021.1938548","article-title":"The role of testosterone treatment in patients with metabolic disorders","volume":"14","author":"Corona","year":"2021","journal-title":"Expert Rev Clin Pharmacol"},{"key":"10.1016\/j.eururo.2025.12.015_b0365","doi-asserted-by":"crossref","first-page":"73","DOI":"10.2174\/1381612825666190206223244","article-title":"Testosterone replacement therapy has limited effect on increasing bone mass density in older men: a meta-analysis","volume":"25","author":"Junjie","year":"2019","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.eururo.2025.12.015_b0370","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s12902-020-0509-6","article-title":"The effects of testosterone on bone health in males with testosterone deficiency: a systematic review and meta-analysis","volume":"20","author":"Zhang","year":"2020","journal-title":"BMC Endocr Disord"},{"key":"10.1016\/j.eururo.2025.12.015_b0375","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1210\/js.2019-00119","article-title":"Testosterone supplementation and cognitive functioning in men-a systematic review and meta-analysis","volume":"3","author":"Buskbjerg","year":"2019","journal-title":"J Endocr Soc"},{"key":"10.1016\/j.eururo.2025.12.015_b0380","doi-asserted-by":"crossref","first-page":"9","DOI":"10.5534\/wjmh.200017","article-title":"Testosterone deficiency and risk of cognitive disorders in aging males","volume":"39","author":"Corona","year":"2021","journal-title":"World J Mens Health"},{"key":"10.1016\/j.eururo.2025.12.015_b0385","doi-asserted-by":"crossref","DOI":"10.1016\/j.exger.2020.111106","article-title":"Effect of testosterone supplementation on sarcopenic components in middle-aged and elderly men: a systematic review and meta-analysis","volume":"142","author":"Parahiba","year":"2020","journal-title":"Exp Gerontol"},{"key":"10.1016\/j.eururo.2025.12.015_b0390","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1002\/jcsm.12291","article-title":"Muscular responses to testosterone replacement vary by administration route: a systematic review and meta-analysis","volume":"9","author":"Skinner","year":"2018","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"10.1016\/j.eururo.2025.12.015_b0395","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1001\/jamapsychiatry.2018.2734","article-title":"Association of testosterone treatment with alleviation of depressive symptoms in men: a systematic review and meta-analysis","volume":"76","author":"Walther","year":"2019","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.eururo.2025.12.015_b0400","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/JRYT3981","article-title":"The effects and safety of testosterone replacement therapy for men with hypogonadism: the TestES evidence synthesis and economic evaluation","volume":"28","author":"Cruickshank","year":"2024","journal-title":"Health Technol Assess"},{"key":"10.1016\/j.eururo.2025.12.015_b0405","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1080\/14740338.2018.1424831","article-title":"The safety of available treatments of male hypogonadism in organic and functional hypogonadism","volume":"17","author":"Corona","year":"2018","journal-title":"Expert Opin Drug Saf"},{"key":"10.1016\/j.eururo.2025.12.015_b0410","doi-asserted-by":"crossref","first-page":"256","DOI":"10.5534\/wjmh.190061","article-title":"Treatment of functional hypogonadism besides pharmacological substitution","volume":"38","author":"Corona","year":"2020","journal-title":"World J Mens Health"},{"key":"10.1016\/j.eururo.2025.12.015_b0415","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1530\/EJE-12-0955","article-title":"Body weight loss reverts obesity-associated hypogonadotropic hypogonadism: a systematic review and meta-analysis","volume":"168","author":"Corona","year":"2013","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.eururo.2025.12.015_b0420","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s12020-022-03195-5","article-title":"Ketogenic state improves testosterone serum levels-results from a systematic review and meta-analysis","volume":"79","author":"Furini","year":"2023","journal-title":"Endocrine"},{"key":"10.1016\/j.eururo.2025.12.015_b0425","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1001\/jama.2024.10816","article-title":"Medications for obesity: a review","volume":"332","author":"Gudzune","year":"2024","journal-title":"JAMA"},{"key":"10.1016\/j.eururo.2025.12.015_b0430","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.3390\/molecules25081987","article-title":"Type 2 diabetes mellitus: a review of multi-target drugs","volume":"25","author":"Artasensi","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.eururo.2025.12.015_b0435","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1056\/NEJMoa2301972","article-title":"Triple-hormone-receptor agonist retatrutide for obesity\u2014a phase 2 trial","volume":"389","author":"Jastreboff","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.eururo.2025.12.015_b0440","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1590\/S1677-5538.IBJU.2014.01.12","article-title":"Long-term results of permanent memotherm urethral stent in the treatment of recurrent bulbar urethral strictures","volume":"40","author":"Atesci","year":"2014","journal-title":"Int Braz J Urol"},{"key":"10.1016\/j.eururo.2025.12.015_b0445","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1080\/17512433.2024.2366505","article-title":"Pharmacological management of testosterone deficiency in men current advances and future directions","volume":"17","author":"Corona","year":"2024","journal-title":"Expert Rev Clin Pharmacol"},{"key":"10.1016\/j.eururo.2025.12.015_b0450","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1093\/sxmrev\/qead003","article-title":"Oral testosterone therapy: past, present, and future","volume":"11","author":"Miller","year":"2023","journal-title":"Sex Med Rev"},{"key":"10.1016\/j.eururo.2025.12.015_b0455","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/sj.ijir.3901618","article-title":"Efficacy of changing testosterone gel preparations (Androgel or Testim) among suboptimally responsive hypogonadal men","volume":"20","author":"Grober","year":"2008","journal-title":"Int J Impot Res"},{"key":"10.1016\/j.eururo.2025.12.015_b0460","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1111\/andr.12137","article-title":"NatestoTM, a novel testosterone nasal gel, normalizes androgen levels in hypogonadal men","volume":"4","author":"Rogol","year":"2016","journal-title":"Andrology"},{"key":"10.1016\/j.eururo.2025.12.015_b0465","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.esxm.2020.01.009","article-title":"Occurrence of pulmonary oil microembolism after testosterone undecanoate injection: a postmarketing safety analysis","volume":"8","author":"Pastuszak","year":"2020","journal-title":"Sex Med"},{"key":"10.1016\/j.eururo.2025.12.015_b0470","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.juro.2018.09.057","article-title":"A 52-week study of dose adjusted subcutaneous testosterone enanthate in oil self-administered via disposable auto-injector","volume":"201","author":"Kaminetsky","year":"2019","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2025.12.015_b0475","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1016\/j.jsxm.2022.03.619","article-title":"The pre-testosterone therapy checklist","volume":"19","author":"Flores","year":"2022","journal-title":"J Sex Med"},{"key":"10.1016\/j.eururo.2025.12.015_b0480","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1097\/JU.0000000000002188","article-title":"The effect of route of testosterone on changes in hematocrit: a systematic review and Bayesian network meta-analysis of randomized trials","volume":"207","author":"Nackeeran","year":"2022","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2025.12.015_b0485","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1210\/er.2017-00234","article-title":"Lessons from the testosterone trials","volume":"39","author":"Snyder","year":"2018","journal-title":"Endocr Rev"},{"key":"10.1016\/j.eururo.2025.12.015_b0490","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1111\/andr.12470","article-title":"EAA clinical guideline on management of bone health in the andrological outpatient clinic","volume":"6","author":"Rochira","year":"2018","journal-title":"Andrology"}],"container-title":["European Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0302283825048675?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0302283825048675?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T18:38:09Z","timestamp":1783017489000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0302283825048675"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":98,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S0302283825048675"],"URL":"https:\/\/doi.org\/10.1016\/j.eururo.2025.12.015","relation":{},"ISSN":["0302-2838"],"issn-type":[{"value":"0302-2838","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Testosterone Therapy in Adult Males with Hypogonadism","name":"articletitle","label":"Article Title"},{"value":"European Urology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eururo.2025.12.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 European Association of Urology. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}